• WHO and Partners agree on a common approach to strengthen Ebola preparedness in unaffected countriesWHO and Partners agree on a common approach to strengthen Ebola preparedness in unaffected countries

    WHO and Partners agree on a common approach to strengthen Ebola preparedness in unaffected countries

    Monday, 27 October 2014

    The World Health Organization (WHO) and partner organizations meeting in Brazzaville have agreed on a range of core actions to support countries unaffected by Ebola in strengthening their preparedness in the event of an outbreak.

  • Federal judge approves consent decree against Dakota LaboratoriesFederal judge approves consent decree against Dakota Laboratories

    Federal judge approves consent decree against Dakota Laboratories

    Wednesday, 04 September 2013

    Dakota Laboratories LLC and its president, Charles L. Voellinger, Sr., are prohibited from manufacturing and distributing drugs until they correct their ongoing violations of the drug manufacturing laws. The U.S. Food and Drug Administration entered into a consent decree of permanent injunction on Aug. 26, 2013 which enjoined the drug maker and distributor for repeated failure to comply with federal drug manufacturing requirements, known as Current Good Manufacturing Practices (cGMPs).

  • Hitting back at noncommunicable diseases in the PacificHitting back at noncommunicable diseases in the Pacific

    Hitting back at noncommunicable diseases in the Pacific

    Wednesday, 04 September 2013

    30 August 2013 -- What do a fitness club in the Cook Islands, backyard gardens in Kiribati and a dispensary in the Federated States of Micronesia have in common? They are all actively engaged in fighting the noncommunicable disease (NCD) crisis in the Pacific by implementing WHOs Package of Essential NCD interventions. In the Pacific region, most deaths are due to noncommunicable diseases.

  • FDA alerts health care providers of adverse reactions associated with steroid injections from Main Street Family Pharmacy in TennesseeFDA alerts health care providers of adverse reactions associated with steroid injections from Main Street Family Pharmacy in Tennessee

    FDA alerts health care providers of adverse reactions associated with steroid injections from Main Street Family Pharmacy in Tennessee

    Saturday, 25 May 2013

    The U.S. Food and Drug Administration is working closely with the Centers for Disease Control and Prevention and Tennessee Board of Pharmacy to investigate reports of seven adverse events associated with steroid injections compounded by Main Street Family Pharmacy, LLC (Main Street) of Newbern, Tenn.

  • Yellow fever vaccination booster not neededYellow fever vaccination booster not needed

    Yellow fever vaccination booster not needed

    Saturday, 25 May 2013

    17 May 2013 -- The yellow fever booster vaccination given ten years after the initial vaccination is not necessary. WHOs Strategic Advisory Group of Experts on immunization (SAGE) has reviewed the latest evidence and concluded that a single dose of vaccination is sufficient to confer life-long immunity against yellow fever disease. This information is crucial for countries where yellow fever is endemic, because it will allow them to reconsider their vaccine scheduling. It is also important for travellers.

  • FDA allows marketing of first A1c test labeled for diagnosing diabetesFDA allows marketing of first A1c test labeled for diagnosing diabetes

    FDA allows marketing of first A1c test labeled for diagnosing diabetes

    Friday, 24 May 2013

    Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals. This is the first HbA1c test that FDA has allowed to be marketed for this use.

  • FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection toolFDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool

    FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool

    Thursday, 25 April 2013

    The U.S. Food and Drug Administration today announced a public-private partnership to help identify counterfeit or substandard anti-malarial medicines, including falsified products, with the deployment of the FDA-developed Counterfeit Detection Device, called CD-3.

  • Emergency response to antimalarial drug resistanceEmergency response to antimalarial drug resistance

    Emergency response to antimalarial drug resistance

    Thursday, 25 April 2013

    25 April 2013 On World Malaria Day, WHO recognizes significant accomplishments in preventing and controlling malaria, but highlights the threat of antimalarial drug resistance in south-east Asias Greater Mekong subregion. WHO is launching a new Emergency Response to Artemisinin Resistance in Phnom Penh, Cambodia. The emergency response framework will guide a major scale-up of WHO-recommended strategies to combat this public health threat.

  • Vaccinating Roma children in BulgariaVaccinating Roma children in Bulgaria

    Vaccinating Roma children in Bulgaria

    Tuesday, 23 April 2013

    23 April 2013 WHOs innovative new "Guide to Tailoring Immunization Programmes", successfully pilot tested in Bulgaria, helps countries reach children in vulnerable communities. World Immunization Week, that began 20 April, promotes one of the worlds most powerful tools for health the use of vaccines to protect, or "immunize", people of all ages against disease.

  • FDA announces voluntary nationwide recall by Balanced Solutions Compounding PharmacyFDA announces voluntary nationwide recall by Balanced Solutions Compounding Pharmacy

    FDA announces voluntary nationwide recall by Balanced Solutions Compounding Pharmacy

    Sunday, 21 April 2013

    Balanced Solutions Compounding Pharmacy (Balanced Solutions), a division of Axium Healthcare Pharmacy, Inc., of Lake Mary, Fla., is voluntarily recalling all lots of its sterile non-expireddrug products due to a lack of sterility assurance and concerns with product quality controls.